Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Submitted by
admin
on June 2, 2009 - 8:40am
Source:
Yahoo/AP
News Tags:
Bayer
cancer
Genzyme
Campath
Headline:
Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Do Not Allow Advertisers to Use My Personal information
